A new MERS vaccine candidate has shown a stable and functional immune response in humans that persists for at least two years after a booster vaccination. The study demonstrates that such durable immunity can be achieved through targeted booster vaccinations, providing an important step toward an effective MERS vaccine.
SourceGerman Center for Infection Research·JournalNature Communications·TypeRandomized controlled/clinical trial·DateJan 28, 2026
Researchers discovered a 'sticky' molecule, P-selectin, that can cause blood clots and organ failure during COVID-19. A new mRNA therapy that drives P-selectin expression provides broad protection against coronavirus infection.
SourceUniversity of Sydney·JournalJournal of Clinical Investigation·TypeExperimental study·DateNov 17, 2025
Researchers discovered a novel coronavirus in bats in Brazil with similarities to the Middle East respiratory syndrome virus. The five bats belonged to two species and showed significant genetic diversity, prompting experiments to determine whether it can infect humans.
SourceFundação de Amparo à Pesquisa do Estado de São Paulo·JournalJournal of Medical Virology·DateMar 13, 2025
Aranet4 Home CO2 Monitor
Aranet4 Home CO2 Monitor tracks ventilation quality in labs, classrooms, and conference rooms with long battery life and clear e-ink readouts.
A phase Ib clinical trial has shown that the MVA-MERS-S vaccine candidate is safe and effective in healthy individuals previously infected with SARS-CoV-2. The vaccine was tested in a placebo-controlled study with no serious vaccine-related side effects, indicating promising results.
SourceGerman Center for Infection Research·JournalThe Lancet Infectious Diseases·TypeRandomized controlled/clinical trial·DateOct 21, 2024
Researchers have discovered that an HIV drug, cobicistat, can stop many coronavirus diseases when given to infected cells at the right concentration. The findings could strengthen antiviral treatments against current and future outbreaks of coronaviruses.
SourceUniversity of Bristol·JournalAntiviral Research·TypeExperimental study·DateDec 5, 2023
Researchers at Gwangju Institute of Science and Technology developed metal-enhanced fluorescence probes for rapid and accurate detection of influenza viruses. The probes showed high sensitivity and specificity, detecting the virus even at low concentrations, with a remarkable accuracy of over 99%.
SourceGIST (Gwangju Institute of Science and Technology)·JournalACS Nano·TypeExperimental study·DateNov 7, 2023
Apple AirPods Pro (2nd Generation, USB-C)
Apple AirPods Pro (2nd Generation, USB-C) provide clear calls and strong noise reduction for interviews, conferences, and noisy field environments.
Researchers identify 32 human monoclonal antibodies that can block SARS-CoV-2, SARS-CoV-1, and MERS-CoV coronaviruses. These antibodies target a vulnerable site on the viral spike protein, offering potential for broad protection against future pandemics.
SourceScripps Research Institute·JournalImmunity·DateFeb 28, 2023
New research reveals that bat virus relatives of MERS-CoV efficiently bind to bat ACE2 receptors as an entry point into cells. However, these viruses only weakly bind to human ACE2 cell receptors and are not known to cause disease outbreaks in people.
SourceUniversity of Washington School of Medicine/UW Medicine·JournalNature·TypeExperimental study·DateDec 7, 2022
Researchers at Harvard's Wyss Institute discover new class of immunostimulatory dsRNAs that potently induce IFN-I production while limiting inflammation. The dsRNAs inhibit pandemic viruses, including SARS-CoV-2, in mouse and human Organ Chip models.
SourceWyss Institute for Biologically Inspired Engineering at Harvard·JournalMolecular Therapy — Nucleic Acids·TypeExperimental study·DateOct 5, 2022
Apple iPhone 17 Pro
Apple iPhone 17 Pro delivers top performance and advanced cameras for field documentation, data collection, and secure research communications.
Researchers discovered a potent universal coronavirus therapy that targets the S2 stalk region of the viral spike protein, highly conserved among beta-coronaviruses. The monoclonal antibody protected against infections when given as an intraperitoneal injection or nasal dose in animal experiments.
SourceUniversity of Alabama at Birmingham·JournalPLOS Pathogens·TypeExperimental study·DateJul 21, 2022
The NIAID plans to identify prototype pathogens with potential to cause significant human disease, building a framework for rapid research and product development. The institute also focuses on priority pathogens known to cause significant human illness or death.
SourceNIH/National Institute of Allergy and Infectious Diseases·DateFeb 2, 2022
Scientists have developed a fusion protein that successfully blocks replication of SARS-CoV-2 and related viruses in cell culture tests. The protein combines ACE2 with human antibody fragments, providing reliable protection against future mutations.
SourceTechnical University of Munich (TUM)·JournalAntiviral Research·TypeExperimental study·DateDec 14, 2021
SAMSUNG T9 Portable SSD 2TB
SAMSUNG T9 Portable SSD 2TB transfers large imagery and model outputs quickly between field laptops, lab workstations, and secure archives.
A team of scientists has identified a compound that shows promise in easing COVID-19 symptoms by targeting the cellular quality-control system damaged by coronaviruses. The compound, AMG PERK 44, was found to halt virus replication and boost lung function in mice infected with MERS.
SourceDOE/Pacific Northwest National Laboratory·JournalmBio·TypeExperimental study·DateNov 1, 2021
A new study reveals that coronaviruses induce substantial apoptosis in host cells, enabling their internal spread. Targeting this process with PERK inhibitors reduces viral pathogenesis and lung damage.
SourceAmerican Association for the Advancement of Science (AAAS)·JournalScience Advances·DateJun 16, 2021
African MERS-CoV strains show lower replication rates and virulence compared to Saudi Arabian strains. Spike protein differences contribute to the disparity, raising concerns about increased transmission and global outbreak risk.
SourceProceedings of the National Academy of Sciences·JournalProceedings of the National Academy of Sciences·DateJun 7, 2021
A synthetic DNA vaccine for MERS-CoV induced robust antibody neutralizing antibodies and cellular immune responses, protecting against MERS-CoV in NHP models. The low-dose regimen with intradermal delivery was more impactful in controlling disease than the higher dose delivered intramuscularly.
SourceThe Wistar Institute·JournalJCI Insight·DateApr 22, 2021
Two monoclonal antibodies targeting the MERS coronavirus spike protein showed promise in a phase 1 clinical trial, being well-tolerated and safe when administered to healthy adults. The study found the experimental antibodies reduced virus levels and tissue damage in lungs.
SourceNIH/National Institute of Allergy and Infectious Diseases·JournalThe Journal of Infectious Diseases·DateFeb 23, 2021
GoPro HERO13 Black
GoPro HERO13 Black records stabilized 5.3K video for instrument deployments, field notes, and outreach, even in harsh weather and underwater conditions.
A recent study published in the American Journal of Roentgenology found that chest CT scans have a low misdiagnosis rate for COVID-19 and can standardize imaging features. However, CT remains limited for distinguishing between specific viruses.
SourceAmerican Roentgen Ray Society·JournalAmerican Journal of Roentgenology·DateMar 5, 2020
Researchers have developed compounds that can block the replication of similar coronaviruses and other disease-causing viruses. The compounds target a shared protein-cutting enzyme essential for viral replication, showing strong activity against some viruses like MERS-CoV.
SourceAmerican Chemical Society·JournalJournal of Medicinal Chemistry·DateFeb 26, 2020
A new study from NIH scientists found that remdesivir successfully prevented MERS-CoV disease in rhesus macaques and improved their condition when given after infection. The results support additional clinical trials of remdesivir for MERS-CoV and COVID-19.
SourceNIH/National Institute of Allergy and Infectious Diseases·JournalProceedings of the National Academy of Sciences·DateFeb 13, 2020
Researchers discovered a delayed and prolonged inflammatory response in diabetic mice infected with MERS-CoV, indicating a malfunction in the body's response to infection. This finding highlights the importance of managing glucose levels in patients with diabetes experiencing respiratory infections.
SourceUniversity of Maryland School of Medicine·DateOct 18, 2019
Sky-Watcher EQ6-R Pro Equatorial Mount
Sky-Watcher EQ6-R Pro Equatorial Mount provides precise tracking capacity for deep-sky imaging rigs during long astrophotography sessions.
A Phase 1 clinical trial found a MERS-CoV vaccine candidate to be well-tolerated and induce robust immune responses in healthy adult volunteers. Over 85% of participants exhibited detectable immune responses after just two vaccinations, with the response persisting throughout the study.
SourceWalter Reed Army Institute of Research·JournalThe Lancet Infectious Diseases·DateJul 24, 2019
New research from the National Institute of Allergy and Infectious Diseases (NIAID) shows that MERS-CoV can adapt to infect cells of a new species, similar to SARS-CoV. This finding suggests that other coronaviruses might be able to do the same, potentially leading to new human infections.
SourceNIH/National Institute of Allergy and Infectious Diseases·JournalCell Reports·DateAug 14, 2018
A new clinical trial is underway to test two human monoclonal antibodies designed to treat MERS-CoV infection. The study will enroll 48 healthy adults and administer escalating doses of the experimental antibodies.
SourceNIH/National Institute of Allergy and Infectious Diseases·DateMay 18, 2018
Celestron NexStar 8SE Computerized Telescope
Celestron NexStar 8SE Computerized Telescope combines portable Schmidt-Cassegrain optics with GoTo pointing for outreach nights and field campaigns.
Researchers from CIRAD and Hong Kong University find MERS-CoV strains in African dromedaries differ from those in the Arabian Peninsula, explaining virus transmission. Genetic differences may account for disease not being transmitted to humans in West and North Africa.
SourceCirad·JournalProceedings of the National Academy of Sciences·DateMar 20, 2018
A new vaccine called Zoonoses Barrier Vaccine (ZBV) aims to prevent the spread of highly pathogenic zoonotic diseases. The vaccine targets deadly pathogens in animal species and has shown promise in preventing devastating diseases such as Lassa haemorrhagic fever, SARS, MERS, plaque, Rift Valley Fever Virus and Q Fever.
Researchers identified a novel coronavirus in a Ugandan bat that is 87% identical to MERS-CoV and 91% identical to NeoCoV. However, the virus has significant differences in its spike gene, making it unlikely to spread to humans.
SourceAmerican Society for Microbiology·JournalmBio·DateApr 4, 2017
Fluke 87V Industrial Digital Multimeter
Fluke 87V Industrial Digital Multimeter is a trusted meter for precise measurements during instrument integration, repairs, and field diagnostics.
A novel coronavirus found in a Ugandan bat is 87% identical to the one causing MERS, but lacks key proteins allowing it to infect humans. Researchers say the virus is unlikely to spread to humans, despite its similarities.
SourceColumbia University's Mailman School of Public Health·JournalmBio·DateApr 4, 2017
A new study suggests that Middle East Respiratory Syndrome coronavirus (MERS-CoV) develops mutations that make the virus less virulent during an outbreak, challenging current vaccine strategies. The study found two specific point mutations in the viral spike protein that impaired fitness and virulence.
SourceAmerican Society for Microbiology·JournalmBio·DateMar 1, 2016
Researchers developed a vaccine effective in protecting dromedaries against MERS-CoV, reducing nasal excretion and transmission. Vaccination may also protect humans at high risk of infection, but further studies are needed to determine duration of protection.
SourceUniversitat Autonoma de Barcelona·JournalScience·DateDec 18, 2015
Recent studies identified five distinct lineages of MERS-CoV in camels, with low barrier for interspecies transmission. A vaccine was found to be effective in preventing clinical symptoms and reducing virus levels in vaccinated camels.
SourceAmerican Association for the Advancement of Science (AAAS)·JournalScience·DateDec 17, 2015
A study compared the population dynamics of MERS-CoV and SARS-CoV infections, finding that MERS-CoV predominantly affects males with multiple chronic conditions. This research highlights key differences between the two diseases, including mortality rates and transmission patterns.
Rigol DP832 Triple-Output Bench Power Supply
Rigol DP832 Triple-Output Bench Power Supply powers sensors, microcontrollers, and test circuits with programmable rails and stable outputs.
Researchers at the NIH have successfully tested an experimental MERS vaccine in monkeys and camels, demonstrating broad protection against different strains of the virus. The vaccine uses a synthetic DNA sequence that combines elements of SARS and MERS-CoV proteins, inducing protective immunity in non-human primates.
SourceNIH/National Institute of Allergy and Infectious Diseases·JournalScience Translational Medicine·DateAug 19, 2015
A two-step regimen of experimental vaccines against Middle East respiratory syndrome (MERS) prompted immune responses in mice and rhesus macaques, producing broadly neutralizing antibodies against multiple strains of the MERS coronavirus. Vaccinated macaques were protected from severe lung damage when later exposed to MERS-CoV.
SourceNIH/National Institute of Allergy and Infectious Diseases·JournalNature Communications·DateJul 28, 2015
The recent MERS-CoV outbreak in Korea spread quickly due to poor infection prevention and control measures, overcrowding, and environmental contamination. The authors emphasize the importance of implementing stringent hospital protocols, contact tracing, and mandatory quarantine for close contacts.
SourceAmerican Thoracic Society·JournalAmerican Journal of Respiratory and Critical Care Medicine·DateJun 29, 2015
A team of researchers from Ludwig-Maximilians-Universität München has developed a candidate vaccine against Middle East Respiratory Syndrome (MERS) and demonstrated its efficacy in a mouse model. The vaccine, named MVA-MERS-S, uses a modified virus to induce protective immunity against the coronavirus.
SourceLudwig-Maximilians-Universität München·JournalJournal of Virology·DateJun 22, 2015
Nikon Monarch 5 8x42 Binoculars
Nikon Monarch 5 8x42 Binoculars deliver bright, sharp views for wildlife surveys, eclipse chases, and quick star-field scans at dark sites.
A team of researchers from Purdue University has identified molecules that inhibit the MERS virus's essential 3C-like protease enzyme. The discovery could lead to better treatments for those infected with MERS. The unique properties of this enzyme make it an attractive target for potential treatments.
SourcePurdue University·JournalJournal of Biological Chemistry·DateJun 22, 2015
Global health experts Lawrence O. Gostin and Daniel Lucey outline strategies for managing the MERS-CoV outbreak, focusing on transparency, trust, and infection control in healthcare settings. Key findings include training health workers and conducting diagnostic testing of travelers to limit quarantines.
SourceO'Neill Institute for National and Global Health Law·JournalJAMA·DateJun 17, 2015
The MERS-CoV virus has been linked to dromedary camels, with little human-to-human transmission reported. The disease can cause severe respiratory symptoms and multiorgan failure, highlighting the need for effective infection prevention and control measures.
New studies suggest that MERS-CoV is unlikely to reach epidemic status due to effective infection control measures. The virus exhibits a high mortality rate, but hospital-acquired infections dominate the epidemiology. Prolonged infection control measures are crucial in severely ill patients with MERS-CoV.
SourceElsevier Health Sciences·JournalInternational Journal of Infectious Diseases·DateDec 11, 2014
A review of 252 papers identified 11 cases of MERS-CoV transmission among healthcare workers, highlighting lapses in infection control. The virus can survive on hospital surfaces for up to 48 hours and is transmissible through vomit and diarrhea.
SourceElsevier Health Sciences·JournalAmerican Journal of Infection Control·DateDec 1, 2014
Meta Quest 3 512GB
Meta Quest 3 512GB enables immersive mission planning, terrain rehearsal, and interactive STEM demos with high-resolution mixed-reality experiences.
Scientists discovered that a common protease enzyme furin activates MERS-CoV to fuse with cell membranes and enter host cells. Blocking this process could lead to treatment by preventing the virus from infecting cells. The study found two cleavage sites on the spike protein, allowing for more spread in animals or humans.
SourceCornell University·JournalProceedings of the National Academy of Sciences·DateOct 13, 2014
Researchers found camels to be the primary reservoir of Middle East respiratory syndrome coronavirus (MERS-CoV), shedding the virus in their nasal secretions for up to 35 days. Vaccinating camels may reduce transmission risk to people and other camels.
SourceNIH/National Institute of Allergy and Infectious Diseases·JournalEmerging Infectious Diseases·DateSep 24, 2014
Researchers at the NIH have developed a new animal model of severe Middle East respiratory syndrome coronavirus (MERS-CoV) infection in marmosets. This model closely mimics the severe pneumonia experienced by people infected with MERS-CoV, making it an ideal option for testing potential treatments.
SourceNIH/National Institute of Allergy and Infectious Diseases·JournalPLOS Pathogens·DateAug 21, 2014
Researchers have identified marmosets as an ideal animal model to study Middle East respiratory syndrome corona virus (MERS-CoV) due to their DPP4 protein's similarity to humans. The marmoset model recapitulates severe respiratory symptoms seen in human patients, making it a promising candidate for future therapeutic studies.
Creality K1 Max 3D Printer
Creality K1 Max 3D Printer rapidly prototypes brackets, adapters, and fixtures for instruments and classroom demonstrations at large build volume.
Researchers found genetic fragments of MERS-CoV in air samples from a camel barn, suggesting short or intermittent shedding of the virus. The study emphasizes the importance of preventing possible airborne transmission and highlights the risk of camel-to-human transmission.
SourceAmerican Society for Microbiology·JournalmBio·DateJul 22, 2014
Researchers at University of Maryland School of Medicine have identified over 60 drugs that could inhibit the Middle East respiratory syndrome coronavirus (MERS-CoV) and severe acute respiratory syndrome coronavirus (SARS-CoV). These drugs, which are either approved for another condition or in advanced clinical trials, provide new targ...
SourceUniversity of Maryland School of Medicine·JournalAntimicrobial Agents and Chemotherapy·DateMay 21, 2014
A new experimental vaccine developed by Novavax has been shown to induce a neutralizing antibody response in mice, blocking infection with the MERS-CoV virus. The vaccine uses recombinant nanoparticle technology and is based on the major surface spike protein of SARS-CoV and MERS-CoV.
SourceUniversity of Maryland School of Medicine·JournalVaccine·DateApr 30, 2014
Apple MacBook Pro 14-inch (M4 Pro)
Apple MacBook Pro 14-inch (M4 Pro) powers local ML workloads, large datasets, and multi-display analysis for field and lab teams.
A nationwide survey in Saudi Arabia found that three-quarters of camels tested had evidence of MERS-CoV infection. The study established direct camel-to-human transmission is possible and likely, highlighting the need for control measures to contain the spread of the disease.
SourceColumbia University's Mailman School of Public Health·JournalmBio·DateFeb 25, 2014
The American College of Physicians has published new research on MERS, highlighting the need for better understanding and collaboration to combat its potential as a major public health threat. Guidelines for cholesterol treatment have also been released, sparking debate among physicians, while expert advice is offered on effective scre...
SourceAmerican College of Physicians·JournalAnnals of Internal Medicine·DateJan 27, 2014
A large genetic analysis of MERS-CoV genomes suggests the virus has transmitted from animals to humans on multiple occasions. The study found that the virus evolved quickly and spread between locations, making it unlikely that a single transmission occurred. Further animal studies are needed to establish the source of the virus.
Genome sequencing of MERS-CoV identified multiple chains of infection, indicating human-to-human transmission is more complicated than expected. The study suggests additional sources of the virus, such as undetected carriers, are involved in its spread.
SourceWellcome Trust Sanger Institute·JournalThe Lancet·DateSep 19, 2013
Apple iPad Pro 11-inch (M4)
Apple iPad Pro 11-inch (M4) runs demanding GIS, imaging, and annotation workflows on the go for surveys, briefings, and lab notebooks.
Recent paper reviews treatment scenarios for SARS, suggesting similar treatments may work for MERS-CoV. The Middle East Respiratory Syndrome Coronavirus has been identified in over 90 patients, with approximately 50% mortality rate.
SourceElsevier·JournalThe Journal of Infectious Diseases·DateSep 13, 2013
Researchers found that a combination of interferon-alpha 2b and ribavirin reduced viral replication and lung damage in monkeys infected with the MERS-CoV virus. The treatment worked by moderating the immune response and promoting repair of damaged lung tissue.
SourceUniversity of Washington·JournalNature Medicine·DateSep 10, 2013
A combination of two licensed antiviral drugs reduces MERS-CoV replication and improves clinical outcomes in rhesus macaques. The treatment group showed no breathing difficulties, minimal pneumonia, lower virus amounts, and less severe tissue damage.
SourceNIH/National Institute of Allergy and Infectious Diseases·JournalNature Medicine·DateSep 8, 2013
Researchers found antibodies specific to MERS-CoV in 100% of serum samples from dromedary camels in Oman, but not in animals from other countries. This suggests that a MERS-CoV-like virus is circulating in dromedary camels, potentially serving as an animal reservoir for the human coronavirus.
SourceThe Lancet_DELETED·JournalThe Lancet Infectious Diseases·DateAug 8, 2013
Kestrel 3000 Pocket Weather Meter
Kestrel 3000 Pocket Weather Meter measures wind, temperature, and humidity in real time for site assessments, aviation checks, and safety briefings.
A new analysis of 47 MERS cases in Saudi Arabia found that most patients had underlying medical conditions and succumbed to the disease. In contrast to SARS, MERS appeared more deadly, with a 60% mortality rate among those with co-existing chronic illnesses.
SourceThe Lancet_DELETED·JournalThe Lancet Infectious Diseases·DateJul 25, 2013
Researchers have found a virus in South African bats that is genetically more closely related to MERS-CoV than any other known virus. This discovery suggests that African bats may play a role in the evolution of MERS-CoV predecessor viruses, potentially leading to human infection through intermediate hosts such as camels.
SourceUniversity of Bonn·JournalEmerging Infectious Diseases·DateJul 24, 2013
Researchers estimate MERS-CoV's basic reproduction number (R0) is 0.69, compared to SARS' 2.2-3.7, suggesting a lower risk of pandemic potential.
SourceThe Lancet_DELETED·JournalThe Lancet·DateJul 4, 2013
A recent study describes a patient with MERS-CoV who died in Munich, revealing the virus replicates in kidneys and circulates differently than SARS. The findings suggest critical implications for diagnosis and infection control, highlighting the need for more genetic data on the new virus.
SourceThe Lancet_DELETED·JournalThe Lancet Infectious Diseases·DateJun 16, 2013